Twice a Day for Three Months. You Still Can’t Tell If It’s Working.
Body · Evidence Review · 8 min read · What two clinical reviews actually found about absorption, and why “bioidentical” was never the question that mattered
Based on the published research of Frank Z. Stanczyk, PhD, Research Professor of Obstetrics & Gynecology, Keck School of Medicine of USC, and Holly L. Thacker, MD, Professor and Director, Center for Specialized Women’s Health, Cleveland Clinic. Stanczyk faculty profile · ResearchGate · Thacker provider profile · LinkedIn
The jar says bioidentical. It doesn’t say how much of what’s inside actually makes it past your skin, and that is the entire question.
The jar has been on the bathroom shelf for three months now. Half a teaspoon, inside the wrist or the soft skin below the collarbone, rotated most nights the way the pharmacist at the health food store explained it. The hot flashes are maybe a little better. Maybe. It’s hard to be sure, and nobody has ever told you how you’d know.
That uncertainty isn’t a personal failure to notice your own body. It’s the accurate description of what the evidence on progesterone cream actually looks like.
This is a reading of published clinical research. Blue Leaf Journal is not a clinical body; the findings below belong to the researchers and clinicians named, and the plain-English rendering is ours.
The short answer: over-the-counter progesterone cream does get absorbed, but not reliably enough, and not into the bloodstream in the way a clinician can measure, to be assumed protective. The clearest clinical statement on this, from Cleveland Clinic reviewers writing for physicians, is direct: no transdermal progesterone cream can be assumed to protect the uterine lining from estrogen’s effects, and creams that rely on wild yam extract alone don’t contain absorbable progesterone at all.¹ A separate pharmacology review found the absorption problem is stranger than “it doesn’t work”: the cream raises progesterone in saliva and capillary blood while barely moving it in the venous blood a lab test actually draws, which is exactly the kind of mismatch that lets two people look at the same cream and reach opposite conclusions.²
The short version, with numbers
- Cleveland Clinic Journal of Medicine reviewers state plainly: “no transdermal progesterone cream can be assumed to protect the endometrium against the stimulatory effects of estrogen,” even at concentrations above 400 mg per ounce.¹
- Creams containing only diosgenin, the plant compound extracted from wild yam, “does not provide an adequate amount of absorbable progesterone,” since the body cannot convert diosgenin into progesterone on its own, no matter how it’s applied.¹
- A 2014 pharmacology review found topical progesterone creams and gels produce very low levels in venous blood, the sample a standard lab test measures, while producing much higher levels in saliva and capillary (fingerstick) blood.²
- The same review notes alcohol-based gels, specifically, may be the one exception worth watching. They appear to reach progesterone levels comparable to the luteal phase of a natural cycle, though the author is clear this is based on limited research.²
- A 2005 pharmacokinetic study found an over-the-counter progesterone cream did produce measurable, significant drug exposure compared with an FDA-approved oral progesterone product, evidence against the idea that these creams are simply inert.³
- What none of this settles: whether the version sitting in your bathroom, at whatever concentration is on its label, is doing enough to protect your uterine lining if you’re also taking estrogen. That is the one question a symptom improvement can’t answer for you.
In this article: Why “it’s absorbed” and “it protects you” are different claims · The blood-test mismatch behind the whole debate · The evidence, source by source · What this means if you’re also taking estrogen · The one move · FAQ
Why does “it’s absorbed” not settle whether progesterone cream works?
Because absorption and protection are two separate claims, and the marketing on the jar quietly merges them into one.
Progesterone is a real hormone with a real, measurable job: opposing estrogen’s effect on the lining of the uterus, so that lining doesn’t grow unchecked. For a cream to do that job, a therapeutic amount has to reach your bloodstream and stay there consistently enough to do the opposing. The 2005 pharmacokinetic study confirms the first part of that sentence is not a fantasy: a commercially available over-the-counter cream produced significant, measurable drug exposure when tested directly against an FDA-approved oral progesterone product.³ Something real crosses the skin.
What that study doesn’t establish, and what no study reviewed here establishes, is that the amount crossing the skin is enough, delivered reliably enough, to protect the endometrium the way a prescription oral or vaginal progesterone is proven to. Pattimakiel and Thacker, writing a clinical review for practicing physicians, close that gap directly: “In general, no transdermal progesterone cream can be assumed to protect the endometrium against the stimulatory effects of estrogen.” They add that this holds “even when concentrations exceed 400 mg per ounce,” which rules out the natural next question, whether a stronger cream solves it.¹
Definition
Diosgenin is a plant steroid found in wild yam and soy. It resembles progesterone chemically, which is why it appears on so many cream labels, but the human body has no enzyme pathway to convert it into actual progesterone. A cream listing wild yam or diosgenin as its only active ingredient is not delivering hormone, regardless of dose or how it’s marketed.¹
That distinction, bioidentical progesterone made in a lab from soy or yam precursors versus diosgenin itself left unconverted, is where a lot of the confusion on the shelf actually lives. Both get called “natural.” Only one contains a hormone your body can use.
Why do some women swear it works when the lab data looks so thin?
Because the lab test and the felt experience may genuinely be measuring different things, and that’s not a contradiction. It’s a documented mismatch in how the hormone shows up in the body.
Frank Stanczyk, a steroid biochemist at USC’s Keck School of Medicine who has spent decades studying how these hormones move through the body, reviewed the evidence on topical progesterone creams and gels for the journal Climacteric in 2014. His finding is the reason two clinicians can look at the same product and disagree in good faith: applied progesterone shows up as “very low serum progesterone levels” (the venous blood draw a standard lab test relies on) while producing meaningfully elevated levels in saliva and in capillary blood, the kind drawn from a fingerstick.²
What the research found
The study. Stanczyk, F. Z. “Treatment of postmenopausal women with topical progesterone creams and gels: are they effective?” Climacteric, 2014, 17(Suppl 2):8–11.²
The finding. Standard venous serum testing likely understates how much progesterone a topical product delivers, because the hormone distributes unevenly between blood compartments after skin absorption. Alcohol-based gels appear to be the exception, reaching serum levels closer to a natural luteal phase, though the author notes this rests on limited data and calls for long-term studies.² The limitation: a review of existing pharmacology explains why measurements disagree. It does not, on its own, prove any specific commercial cream protects the endometrium.
Put plainly: your venous blood test can look unimpressive while your saliva and capillary levels, and possibly your symptoms, tell a different story. That is a real, published finding, not a wellness-industry excuse for a null result. It’s also exactly why “I feel better” and “this is proven to protect you” remain two different sentences, even when they’re both true for the same jar.
If the not-knowing here is one item on a much longer list of things you’re quietly monitoring for your own body, the Quiet Audit is ten private minutes to name the whole list at once. Start here.
The evidence, source by source
| Source | Type | Finding | Limitation |
|---|---|---|---|
| Pattimakiel & Thacker, 2011¹ | Clinical review, Cleveland Clinic Journal of Medicine | No transdermal cream can be assumed to protect the endometrium; diosgenin-only creams deliver no usable hormone | A review synthesizing prior evidence for clinicians, not a new trial of a specific product |
| Stanczyk, 2014² | Pharmacology review, Climacteric | Low venous serum levels, higher saliva/capillary levels; alcohol-based gels may be a partial exception | Author explicitly calls for long-term studies; evidence on gels described as sparse |
| Hermann et al., 2005³ | Pharmacokinetic comparison study | An OTC progesterone cream produced significant, measurable drug exposure versus an FDA-approved oral product | Demonstrates absorption occurs; does not establish endometrial protection |
Something crosses the skin. Whether enough of it reaches the one place that matters is the part still unproven.
Who else has measured this
Lynn Pattimakiel, MD, staff physician in the Department of Internal Medicine at Cleveland Clinic and its Center for Specialized Women’s Health, board certified in internal medicine and certified as a menopause practitioner. She co-authored the 2011 review this article leans on most heavily.¹
Cleveland Clinic profile · Doximity
Holly L. Thacker, MD, Professor and Director of the Center for Specialized Women’s Health at Cleveland Clinic and the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, and a North American Menopause Society–certified menopause specialist. She is the review’s senior author.¹
Cleveland Clinic provider profile · Speaking of Women’s Health · LinkedIn
What does this actually mean if you’re also taking estrogen?
It means the stakes of “probably fine” are higher than they are for a supplement that simply might not help.
Unopposed estrogen, meaning estrogen without enough progesterone actively opposing it, is a known driver of endometrial thickening over time in a woman who still has a uterus. That’s precisely the job progesterone cream is often bought to do alongside an estrogen patch, gel, or pill: keep the lining in check without a prescription. Thacker and Pattimakiel’s review is written for physicians for exactly this reason, and their conclusion doesn’t hedge: transdermal progesterone “should be avoided” as endometrial protection, because it “does not protect against endometrial cancer” reliably enough to rely on.¹
That’s a different risk category than “the hot flashes might not improve.” A cream that underdelivers on hot flash relief costs you money and patience. A cream that underdelivers on endometrial protection, while you and your prescriber both assume it’s covering that job, is the scenario this evidence is specifically warning against.
| What you might be using it for | What the evidence actually supports |
|---|---|
| General symptom relief, tried on its own | Possible real effect, unproven and inconsistent by product² |
| Endometrial protection alongside estrogen therapy | Not established. Reviewers advise against relying on it for this¹ |
| A diosgenin/wild-yam-only cream, any use | Contains no absorbable progesterone regardless of dose¹ |
| An alcohol-based progesterone gel specifically | The one category with early evidence of luteal-range serum levels, still under-researched² |
The one move: bring the actual label to the appointment that’s already scheduled
Not a new appointment. The next one you already have.
Take a photo of the ingredient list and concentration on your current progesterone cream, or the jar itself, and bring it. Ask two direct questions: does this ingredient list contain USP progesterone or only diosgenin, and if I’m also on estrogen, does this specific product replace or supplement my endometrial protection. Those two questions convert a vague “is this working” worry into a specific answer your prescriber can actually give.
This doesn’t require switching products today, and it isn’t a verdict that the cream is worthless. It’s the fastest way to find out whether the thing on your bathroom shelf is doing the job you’ve been assuming it’s doing.
Frequently asked questions
Does progesterone cream actually get absorbed into the body?
Some does. A 2005 pharmacokinetic study found an over-the-counter cream produced significant, measurable drug exposure compared with an FDA-approved oral progesterone product.³ The open question isn’t whether anything crosses the skin. It’s whether a consistent, therapeutic amount does.
Can progesterone cream protect my uterus if I’m taking estrogen?
Clinical reviewers advise against assuming it can. Cleveland Clinic Journal of Medicine authors state plainly that no transdermal progesterone cream can be assumed to protect the endometrium against estrogen’s effects, even at high concentrations.¹ If you’re on estrogen therapy and using a cream for this purpose, that’s worth a direct conversation with your prescriber.
Why do lab tests sometimes show almost no progesterone even when I feel a difference?
A 2014 pharmacology review found topical progesterone produces low levels in venous serum, the sample a standard blood draw measures, while producing higher levels in saliva and capillary blood.² That mismatch is documented, not imagined, though it doesn’t by itself prove any specific cream is protective.
Is wild yam cream the same as bioidentical progesterone?
No. Diosgenin, the compound in wild yam, cannot be converted into progesterone by the human body. A cream listing only diosgenin or wild yam extract as its active ingredient contains no usable hormone, regardless of concentration or how it’s applied.¹
Is there any topical progesterone formulation with stronger evidence behind it?
Alcohol-based progesterone gels show early evidence of reaching serum levels comparable to a natural luteal phase, according to the same 2014 review. The author is explicit that this rests on limited research and calls for longer studies before treating it as settled.²
Most women reach for a cream because of symptoms that are not happening in the skin at all — sleep, mood, concentration. Where those symptoms actually originate is worth knowing before you judge whether anything is working.
The one move
Photograph your progesterone cream’s ingredient list and bring it to your next scheduled appointment. Ask whether it contains real progesterone, and whether it’s meant to be your endometrial protection if you’re also on estrogen.
If tracking what’s actually proven, for every product on your shelf, has quietly become its own second job, the Quiet Audit is a short private way to see the whole list at once. Start here.
The cream might be doing something. What the evidence won’t let anyone say yet is that it’s doing everything the label implies, and that gap is worth closing with your prescriber rather than guessing at alone.
Related reading: what hormone therapy trials actually measured for memory, the bone-density timeline nobody shows you, and the heat that arrives on no schedule.
On the researchers. Frank Stanczyk is a reproductive steroid biochemist, not a treating clinician; his review evaluates pharmacology across the published literature and does not test any single commercial product. Lynn Pattimakiel and Holly Thacker are practicing clinicians writing guidance for other physicians; their review doesn’t diagnose or treat any individual reader.
Sourcing, disclosure and disclaimers
This is not medical advice. Blue Leaf Journal publishes general information for a general readership. Nothing here is a diagnosis, a treatment recommendation, or a substitute for care from a clinician who knows your history and medications.
We are not clinicians. Blue Leaf Journal is an independent publication and its bylines carry no medical or academic credential. We read published research and translate it. The findings belong to the researchers and institutions named and linked above; the plain-English rendering is ours, and so is any error in it.
No affiliation and no endorsement. Blue Leaf Journal has no affiliation with, and no endorsement from, Frank Z. Stanczyk, the Keck School of Medicine of USC, Lynn Pattimakiel, Holly L. Thacker, Cleveland Clinic, the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, the North American Menopause Society, or any journal named here.
No commercial relationship. No product, brand, or cream named or implied here paid for or was paid for this coverage. There are no affiliate links and no sponsored placements in this article.
How this was checked. Every figure and quotation above was checked against the cited source on 16 September 2026. If you find something we’ve got wrong, write to miriamalderton@blueleafjournal.com and it will be corrected in place, noted here with the date.
References
1. Pattimakiel, L., and Thacker, H. L. “Bioidentical hormone therapy: Clarifying the misconceptions.” Cleveland Clinic Journal of Medicine, 2011, 78(12):829–836. ccjm.org · PubMed
2. Stanczyk, F. Z. “Treatment of postmenopausal women with topical progesterone creams and gels: are they effective?” Climacteric, 2014, 17(Suppl 2):8–11. PubMed
3. Hermann, A. C., Nafziger, A. N., Victory, J., et al. “Over-the-Counter Progesterone Cream Produces Significant Drug Exposure Compared to a Food and Drug Administration-Approved Oral Progesterone Product.” The Journal of Clinical Pharmacology, 2005, 45(6):614–619. PubMed
Keep reading
Miriam Alderton is Research Editor at Blue Leaf Journal. She reads the methods section first and the abstract last, and every figure in this piece is linked to its source above.
Written by Miriam Alderton for Blue Leaf Journal. Updated: 2026-09-16.
